Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton’s tyrosine kinase inhibitor

MLA

Alison H. Kucharik, Md, et al. “Pseudoangiosarcoma and Cutaneous Collagenous Vasculopathy in a Patient on a Bruton’s Tyrosine Kinase Inhibitor.” JAAD Case Reports, vol. 51, no. 17–21, Sept. 2024, pp. 17–21. EBSCOhost, https://doi.org/10.1016/j.jdcr.2024.06.011.

APA

Alison H. Kucharik, M., Nina B. Curkovic, B., Julio C. Chavez, M., Kenneth Y. Tsai, M., PhD, Andrew S. Brohl, M., & James M. Grichnik, M., PhD. (2024). Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton’s tyrosine kinase inhibitor. JAAD Case Reports, 51(17–21), 17–21. https://doi.org/10.1016/j.jdcr.2024.06.011

Chicago

Alison H. Kucharik, Md, Bs Nina B. Curkovic, Md Julio C. Chavez, Md Kenneth Y. Tsai PhD, Md Andrew S. Brohl, and Md James M. Grichnik PhD. 2024. “Pseudoangiosarcoma and Cutaneous Collagenous Vasculopathy in a Patient on a Bruton’s Tyrosine Kinase Inhibitor.” JAAD Case Reports 51 (17–21): 17–21. doi:10.1016/j.jdcr.2024.06.011.